Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-Like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of Preeclampsia: The SaPPPhirE Study. Issue 2 (February 2018)
- Record Type:
- Journal Article
- Title:
- Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-Like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of Preeclampsia: The SaPPPhirE Study. Issue 2 (February 2018)
- Main Title:
- Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-Like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of Preeclampsia
- Authors:
- Agrawal, Swati
Cerdeira, Ana Sofia
Redman, Christopher
Vatish, Manu - Abstract:
- Abstract : Preeclampsia is a major cause of morbidity and mortality worldwide. Numerous candidate biomarkers have been proposed for diagnosis and prediction of preeclampsia. Measurement of maternal circulating angiogenesis biomarker as the ratio of sFlt-1 (soluble FMS-like tyrosine kinase-1; an antiangiogenic factor)/PlGF (placental growth factor; an angiogenic factor) reflects the antiangiogenic balance that characterizes incipient or overt preeclampsia. The ratio increases before the onset of the disease and thus may help in predicting preeclampsia. We conducted a meta-analysis to explore the predictive accuracy of sFlt-1/PlGF ratio in preeclampsia. We included 15 studies with 534 cases with preeclampsia and 19 587 controls. The ratio has a pooled sensitivity of 80% (95% confidence interval, 0.68–0.88), specificity of 92% (95% confidence interval, 0.87–0.96), positive likelihood ratio of 10.5 (95% confidence interval, 6.2–18.0), and a negative likelihood ratio of 0.22 (95% confidence interval, 0.13–0.35) in predicting preeclampsia in both high- and low-risk patients. Most of the studies have not made a distinction between early- and late-onset disease, and therefore, the analysis for it could not be done. It can prove to be a valuable screening tool for preeclampsia and may also help in decision-making, treatment stratification, and better resource allocation. Abstract : Supplemental Digital Content is available in the text.
- Is Part Of:
- Hypertension. Volume 71:Issue 2(2018:Feb.)
- Journal:
- Hypertension
- Issue:
- Volume 71:Issue 2(2018:Feb.)
- Issue Display:
- Volume 71, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 71
- Issue:
- 2
- Issue Sort Value:
- 2018-0071-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2018-02
- Subjects:
- biomarkers -- placenta growth factor -- preeclampsia -- pregnancy -- sFLT-1 protein, human
Hypertension -- Periodicals
Hypertension -- Treatment -- Periodicals
616.132005 - Journal URLs:
- http://hyper.ahajournals.org ↗
http://journals.lww.com ↗ - DOI:
- 10.1161/HYPERTENSIONAHA.117.10182 ↗
- Languages:
- English
- ISSNs:
- 0194-911X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4352.629000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 6315.xml